Teenagers Should Get Meningitis B Jab on NHS from Age 15, Health Experts Say

The Joint Committee on Vaccination and Immunisation’s recommendation to offer meningitis B vaccinations to all teenagers at around age 15 is long overdue. The justification for this move lies in the disturbing reality of the disease’s impact on young people.

This year’s outbreak in Kent was one of the deadliest, with two teenagers losing their lives. However, it was not an isolated incident; smaller clusters have occurred across the UK since then. These outbreaks are a stark reminder that meningitis B remains a significant public health concern.

The committee’s proposal is to offer vaccinations at age 15 for those who received the menB jab as infants and provide catch-up programs for those who missed out on this initial protection. This will safeguard not only young people but also their loved ones, who often cope with the emotional trauma of a meningitis B diagnosis.

Cases tend to peak in October and November each year, which is why the timing of the recommendation is crucial. The data suggests that the menB vaccine provides strong protection for at least five years after vaccination, a critical period for young adults living away from home in close proximity with others.

According to Dr. Shamez Ladhani, consultant epidemiologist at the UK Health Security Agency, low population immunity against meningitis B is likely the cause of these clusters this year. The cycles of meningococcal disease go through periods of 20 to 30 years, with cases rising when population immunity wanes.

The JCVI’s proposal to start vaccinating teenagers at age 15 responds to this cycle and acknowledges the families who have been advocating for better protection against meningitis B. The vaccination program will provide a shield not just against the disease but also against the fear and anxiety that accompany it.

Around one million Year 13 pupils and those under 25 starting university this autumn are already being offered the menB vaccine on the NHS, laying groundwork for this initiative. However, the JCVI’s recommendation highlights the need for a more comprehensive approach to meningitis B prevention.

Dr. Wei Shen Lim noted that two doses of the menB vaccine are necessary at least 28 days apart for full protection. Timely implementation and effective communication with young people about the importance of vaccination will be crucial to the program’s success.

The JCVI’s recommendation to offer meningitis B vaccinations to teenagers at age 15 is a vital step towards reducing the burden of this disease in the UK. It demonstrates the ongoing efforts of health experts and advocates who have pushed for better protection against meningitis B. With continued vigilance and proactive measures, we can hope to see a decline in cases and a significant reduction in the emotional toll of this devastating disease.